Risk appetite turned sour on back of heavy selling by exchange traded funds in the cash and futures market segment.
The foreign institutional investors sold shares worth a net Rs 368.39 crore on 3 April 2013, as per provisional data from the stock exchanges. FIIs have invested over $10 billion this year and have been the biggest factor in supporting markets despite sluggish growth and weak macro.
Also Read
Mirroring the domestic macro-economic concerns, the Bombay Stock Exchange's 30-share index Sensex dropped 291.94 points to end at 18,509.70 while the National Stock Exchange's 50-share Nifty shed 98.15 points at 5,574.75.
“The political scenario back home is not conducive to invest. If Advani says elections can happen early then it can happen, may be in November,” said Deven Choksey, MD, KR Choksey today.
Global risk appetite also remained frail after weak economic reports on hiring and service industry growth in the U.S fuelled concerns over growth recovery in the world’s biggest economy.
Asian shares ended mixed with Japan's Nikkei notching 2% to 12,634.54 after Bank of Japan’s bold easing measures while Strait Times declined 0.3% to 3,313 today. Markets in Hong Kong, Taiwan and China were shut today for a holiday.
The next major global cue is monetary policy from European Central Bank President Mario Draghi later in the day.
Back home, all the key sectoral indices ended lower with real-estate, IT, banks, consumer durable, metal sectors leading the drop on BSE.
The laggards included counters such as Tata Steel and Jindal Steel dropping 4% each, SBI and ICICI Bank fell 2% each, Sterlite and Hindalco Industries shed 3% and 2% respectively while Infosys dropped 2.7% on BSE.
The gainers on the Sensex were Coal India adding nearly 2.6%, Dr Reddy’s up 3% , while HUL rose 2% on BSE.
Shares of information technology (IT) companies were under pressure on the bourses on concerns of lower earnings growth for the four quarter ended March (Q4FY2013).
HCL Technologies, Infosys and TCS fell nearly 2%, while Mahindra Satyam, Wipro and Mphasis were down by around 1% each on the Bombay Stock Exchange (BSE).
Bucking the market trend were shares of sugar manufacturers that rallied up to 9% on hopes that the government may soon remove some curbs on the tightly controlled sector.
Bajaj Hindustan and Shree Renuka Sugars rallied almost 9% to Rs 21.65 and Rs 25.35 respectively on BSE.
The notable movers included, Indraprastha Gas (IGL) dipped 2.7% to Rs 270.5 on back of heavy volumes on reports that the Supreme Court has deferred its case hearing against Petroleum and Natural Gas Regulatory Board (PNGRB) to April 16.
Hyderabad-based pharmaceutical major Dr Reddy’s Laboratories (DRL) gained 3% as it launched zoledronic acid injection in the US market following approval by the United States Food & Drug Administration (USFDA).
The broader markets slumped with mid-caps and small-caps declining nearly 2% on BSE.
The market breadth ended weak. Out of 2,866 stocks traded, 1,842 stocks declined compared to 911 advances on BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)